Gynaecological Care for Transgender People in France in 2024.
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Apr 4, 2024
Trial Information
Current as of November 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Gynaecological Care for Transgender People in France in 2024," is focused on understanding the gynecological health of transgender individuals who are undergoing hormone therapy to align their physical bodies with their gender identity. As more transgender people seek gender-affirming hormone therapy, there is a growing need to learn more about how this treatment affects their gynecological health. The study aims to gather information and suggest follow-up care specifically for transgender individuals.
To participate in this trial, individuals must be French-speaking transgender people (either transgender women or transgender men) aged 18 years or older. Participants can expect to share their experiences and health information, helping researchers gain a better understanding of gynecological care needs in this community. This trial is currently recruiting participants, and it’s an important step toward improving healthcare for transgender individuals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • French-speaking transgender person (transgender women or transgender men)
- • age ≥18 years
- Exclusion Criteria:
- • age \<18 years
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pessac, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported